Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.
about
Multivalent Carbohydrate-Lectin Interactions: How Synthetic Chemistry Enables Insights into Nanometric RecognitionFine-tuning of prototype chicken galectins: structure of CG-2 and structure-activity correlationsNatural single amino acid polymorphism (F19Y) in human galectin-8: detection of structural alterations and increased growth-regulatory activity on tumor cellsGalectin fingerprinting in naso-sinusal diseases.Hydrodynamic properties of human adhesion/growth-regulatory galectins studied by fluorescence correlation spectroscopyProteomics in pancreatic cancer research.A regulatory network of two galectins mediates the earliest steps of avian limb skeletal morphogenesis.Galectins as tools for glycan mapping in histology: comparison of their binding profiles to the bovine zona pellucida by confocal laser scanning microscopy.Symmetric dithiodigalactoside: strategic combination of binding studies and detection of selectivity between a plant toxin and human lectins.Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function.Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T-cell suppressionStructural aspects of binding of α-linked digalactosides to human galectin-1Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.Tumor-Associated Glycans and Immune SurveillanceThermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.Clinical implication of the serum galectin-1 expression in epithelial ovarian cancer patients.VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancerInhibition of human retinal pigment epithelial cell attachment, spreading, and migration by the human lectin galectin-1.Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoproteinBeyond glycoproteins as galectin counterreceptors: tumor-effector T cell growth control via ganglioside GM1 [corrected].Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target.The third dimension of reading the sugar code by lectins: design of glycoclusters with cyclic scaffolds as tools with the aim to define correlations between spatial presentation and activity.Introduction to glycopathology: the concept, the tools and the perspectivesSialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis.Galectin-1 Couples Glycobiology to Inflammation in Osteoarthritis through the Activation of an NF-κB-Regulated Gene Network.Conformational selection in glycomimetics: human galectin-1 only recognizes syn-Ψ-type conformations of β-1,3-linked lactose and its C-glycosyl derivative.Lectins: getting familiar with translators of the sugar code.Cyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells.Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrin.Sweet complementarity: the functional pairing of glycans with lectins.Open Wound Healing In Vivo: Monitoring Binding and Presence of Adhesion/Growth-Regulatory Galectins in Rat Skin during the Course of Complete Re-Epithelialization.Lipid glycosylation: a primer for histochemists and cell biologists.Galectins: their network and roles in immunity/tumor growth control.Upregulation of IL-6, IL-8 and CXCL-1 production in dermal fibroblasts by normal/malignant epithelial cells in vitro: Immunohistochemical and transcriptomic analyses.Regulatory Impact of Amniotic Membrane Transplantation on Presence of Adhesion/Growth-Regulatory Galectins-1 and -7 in Corneal Explants from Acanthamoeba Keratitis Patients: Clinical Note.Structural significance of galectin design: impairment of homodimer stability by linker insertion and partial reversion by ligand presence.Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.Preliminary X-ray crystallographic analysis of an engineered variant of human chimera-type galectin-3 with a shortened N-terminal domain.Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas.Functional interplay between ganglioside GM1 and cross-linking galectin-1 induces axon-like neuritogenesis via integrin-based signaling and TRPC5-dependent Ca²⁺ influx.
P2860
Q26749071-DC54B9DF-495F-4265-BAC9-82B9116388F1Q27685442-D615D939-12B2-4139-969F-267A22BCBC2EQ27688879-6678DEF7-2292-4EF0-BCA0-BBB4E934F486Q30436202-4CCDC4AF-E2F8-417E-BBBC-985DBCD0F5C7Q33605492-5A6EF343-6633-4C04-89E2-D7C5F5712DD6Q33791981-06717456-D7A9-4EFD-8B19-801D10EC64BFQ33810026-58A5E430-BDCD-4740-8315-ABD27CADF094Q33902518-D7D78BA7-F6C2-4828-9715-75CE15F0AAABQ33928742-334B977F-867F-42F8-A017-3232593064E5Q34676070-A8859E27-7A42-4807-BB9F-2BAF2636424EQ35180105-CF6F20A7-16EF-4D21-99FD-9882D3EA38D7Q35559685-1DF2214B-DC96-4280-9473-3E9FB32114CEQ35723085-C843B982-E4F0-4141-B49E-D25B1B447841Q35890610-6A500751-8871-4DAF-BCDB-369FEC2CE196Q35904166-0548E95A-E451-4C64-A8D3-7EC8249464D1Q36304002-3C87F254-DD89-4BD7-8E76-C42CD8D4FF81Q37296108-61F12C4D-464B-4864-8F5E-C4CDDE1E441DQ37412929-DA7E6371-F17A-4687-978D-EF24C32ACCE8Q37690232-312A331D-C77D-4497-9B1F-8D651124070AQ38004594-C561C974-7170-471B-8BB8-917A178313E3Q38071660-A5E4BCFB-61BD-4EFF-8D85-B8D939320C31Q38096239-05DF9C32-28C8-4459-867C-4A0F09B89434Q38180146-5AAAFA04-1A75-4913-89A8-BA3460B6C0ECQ38288649-5C7E61CF-775C-493D-A8C0-A74EE36C46FFQ38294225-CFEF860D-DE9E-4F52-9A19-79B711A6BD20Q38312051-2062FBBC-E0DC-4DC7-A38E-8FAE100819FFQ38332609-75DD2BA9-9C8D-4729-92A6-B3B32F2892ABQ38337529-AD7A3D96-6B99-4553-9470-9FFA1A8E2732Q38339024-E8630987-46D5-4384-8F7D-DC98BA2363D4Q38766179-0665F995-9453-4D1A-86D6-CC676B421239Q38978059-FD32FDEF-381D-41C9-9C81-073051BBB3DDQ39045114-84A8877C-59D5-4638-AD46-F6F053BAD229Q39052321-5AD95F92-E9CB-41AB-A88C-154D68C78CF2Q39264263-FC0AB62F-51CA-4C83-8881-BBDF97E8DE17Q41016662-70F36097-14AA-4E71-8D84-4206AC14009BQ41183639-292F203B-3065-48D4-B025-D3018A594081Q41334598-56C69CA7-3A3B-4EEF-A293-D38888EA6D48Q41873777-AB2E7F77-8688-462C-A16E-8F818DD813B4Q42507266-F847BEA6-518A-41D8-9163-FCE4D4DC7082Q42688469-003D628F-744C-4C3F-9BE4-2D7BCB85263E
P2860
Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor suppressor p16INK4a--mod ...... in pancreatic carcinoma cells.
@en
type
label
Tumor suppressor p16INK4a--mod ...... in pancreatic carcinoma cells.
@en
prefLabel
Tumor suppressor p16INK4a--mod ...... in pancreatic carcinoma cells.
@en
P2093
P2860
P50
P1433
P1476
Tumor suppressor p16INK4a--mod ...... in pancreatic carcinoma cells.
@en
P2093
Corina Böck
Hiroaki Nakagawa
Hugo Sanchez-Ruderisch
Jürgen Kopitz
Katharia M Detjen
Kisaburo Deguchi
Magnus von Knebel Doeberitz
Malte Buchholz
Pia Forberich
Shin-Ichiro Nishimura
P2860
P304
P356
10.1111/J.1742-4658.2007.05851.X
P407
P577
2007-05-29T00:00:00Z